Compare SDHC & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SDHC | TMCI |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.7M | 174.6M |
| IPO Year | 2024 | 2021 |
| Metric | SDHC | TMCI |
|---|---|---|
| Price | $20.61 | $2.63 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 5 |
| Target Price | ★ $16.70 | $4.21 |
| AVG Volume (30 Days) | 70.7K | ★ 903.6K |
| Earning Date | 03-11-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $998,173,000.00 | $218,879,000.00 |
| Revenue This Year | $0.60 | $3.25 |
| Revenue Next Year | $7.10 | $0.99 |
| P/E Ratio | $95.34 | ★ N/A |
| Revenue Growth | ★ 10.26 | 7.90 |
| 52 Week Low | $15.00 | $2.36 |
| 52 Week High | $26.12 | $10.79 |
| Indicator | SDHC | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 59.53 | 41.59 |
| Support Level | $17.03 | $2.57 |
| Resistance Level | $18.28 | $2.99 |
| Average True Range (ATR) | 1.04 | 0.19 |
| MACD | 0.43 | 0.05 |
| Stochastic Oscillator | 72.32 | 34.85 |
Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.